Eosinophilic esophagitis (EoE) continues to increase in prevalence. Allergists are now frequently being asked to actively participate in the management of children and adults with EoE. While several management approaches, including PPIs, dietary restriction therapies and swallowed topical corticosteroids, are clearly documented to successfully treat patients with EoE, most of the evidence is based on short-term trials. Very little guidance exists regarding long-term management of these patients. Allergists are often faced with tough decisions, such as: when, and how often, to perform food challenges in patients on dietary restriction therapies; how long to continue swallowed topical corticosteroids and whether they can decrease the dose over time; how to incorporate combination therapies in the long-term care of EoE patients; and balancing long-term therapy choices with the patient's individual lifestyle. Finally, maintaining coordination of care between the allergist and the gastroenterologist in this disease is crucial. This seminar will review the available data on these topics, and allow for discussion of them with an allergist/immunologist and a gastroenterologist.

Credit claiming for this activity will be available through December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee.